Company profile
Exlites Holdings International, Inc.
OTC: EXHI · Healthcare · Medical - Distribution
#1062 of 1,418 Healthcare companies by revenuebottom-quartile growth
EA Score
54DFH 66DQ —GM 17SS 52
v0.1 · 45/100 weight · provisional
↑ Altman-Z, balance-sheet leverage · ↓ growth stability, Piotroski F
Methodology →Revenue TTM
$71.6k
Rev growth YoY (TTM)
-30.8%
Net income (FY)
-$43.5k
Employees
—
as of 2026-08-21
Market cap
$15.9M
as of 2026-08-21
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$71.0k$71.0k2025
Net income-$43.5k-$43.5k2025
Operating income-$43.5k-$43.5k2025
Total assets$445.7k$445.7k2023
Liabilities$33.8k$33.8k2023
Equity$412.0k$412.0k2023
Revenue trend
FY1996 – FY2025 · USD
FY96
FY97
FY14
FY15
FY22
FY23
FY24
FY25
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is Exlites Holdings International, Inc.’s revenue?
Exlites Holdings International, Inc. booked $71.0k in FY2025 revenue, contracting 29% year over year — slower than 76% of Healthcare companies we track, at a -61.3% net margin.
Peers · Healthcare
IMAC Holdings, Inc.——Paranovus Entertainment Technology Ltd.——PAVmed Inc.40DeXoZymes, Inc.24DOncotelic Therapeutics, Inc.46DMYND Life Sciences Inc.——Neighbors
Salt Lake →Key facts
CEOMark Julian
SectorHealthcare
IndustryMedical - Distribution
HeadquartersSalt Lake City, UT
ExchangeOTC: EXHI
Employees—
IPO date2014-09-12
Latest filings
No filings loaded — no CIK (non-SEC filer).
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.